Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma

Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma

Aberrant expression of chromatin regulators (CRs) could lead to the development of various diseases including cancer. However, the biological function and prognosis role of CRs in colon adenocarcinoma (COAD) remains unclear. We performed the clustering analyses for expression profiling of COAD downl...

Full description

Bibliographic Details
Main Authors:	Wenlong Yang, Chenhua Luo, Shan Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Genetics
Subjects:	colon adenocarcinoma chromatin regulator TCGA prognostic immune infiltration
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.986325/full

Similar Items

Identification and validation of calcium extrusion-related genes prognostic signature in colon adenocarcinoma
by: Mingpeng Jin, et al.
Published: (2024-07-01)

Development of a risk model based on immune genes in patients with colon adenocarcinoma
by: Laiming Wei, et al.
Published: (2023-02-01)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
by: Chong Li, et al.
Published: (2023-06-01)

A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients
by: Zesi Liu, et al.
Published: (2022-10-01)

Identification of lymph node metastasis-related genes and patterns of immune infiltration in colon adenocarcinoma
by: Haoxiang Zhang, et al.
Published: (2023-01-01)

Identification of PANoptosis associated lncRNAs associated with clinical prognosis and immune infiltration microenvironment in colon adenocarcinoma
by: Yangyang Wang, et al.
Published: (2025-01-01)

Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma
by: Ye Wang, et al.
Published: (2022-11-01)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
by: Sijin Sun, et al.
Published: (2020-08-01)

Ferroptosis-related gene signature and clinical prognostic factors as prognostic marker for colon adenocarcinoma
by: Qunzhang Zeng, et al.
Published: (2024-07-01)

The multi-omics analysis identifies a novel cuproptosis-anoikis-related gene signature in prognosis and immune infiltration characterization of lung adenocarcinoma
by: Guanyu Jiang, et al.
Published: (2023-03-01)

Prognostic value of antitumor drug targets prediction using integrated bioinformatic analysis for immunogenic cell death-related lncRNA model based on stomach adenocarcinoma characteristics and tumor immune microenvironment
by: Dayong Ding, et al.
Published: (2022-10-01)

Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis
by: Jihang Luo, et al.
Published: (2020-11-01)

Aberrantly hypermethylated ARID1B is a novel biomarker and potential therapeutic target of colon adenocarcinoma
by: Salem Baldi, et al.
Published: (2022-10-01)

An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas
by: Kangjie Zhou, et al.
Published: (2022-05-01)

Novel six-gene prognostic signature based on colon adenocarcinoma immune-related genes
by: Rui Zhou, et al.
Published: (2022-10-01)

Prognostic Model Associated with Necroptosis in Colorectal Cancer based on Transcriptomic Analysis and Experimental Validation
by: Yuying Huang, et al.
Published: (2024-03-01)

In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma
by: Yue Wang, et al.
Published: (2022-09-01)

Construction and validation of a novel prognostic signature for uveal melanoma based on five metabolism-related genes
by: Han Zhao, et al.
Published: (2021-09-01)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma
by: Ying Guo, et al.
Published: (2023-07-01)

Integrated single-cell and transcriptome sequencing analyses determines a chromatin regulator-based signature for evaluating prognosis in lung adenocarcinoma
by: Qingtong Shi, et al.
Published: (2022-10-01)

Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma
by: Han Nan, et al.
Published: (2023-03-01)

Tumor subtypes and signature model construction based on chromatin regulators for better prediction of prognosis in uveal melanoma
by: Yue Li, et al.
Published: (2023-06-01)

Construction of a prognostic model for colorectal adenocarcinoma based on Zn transport-related genes identified by single-cell sequencing and weighted co-expression network analysis
by: Hua Chen, et al.
Published: (2023-09-01)

Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma
by: Cong Liu, et al.
Published: (2022-11-01)

FRZB: a potential prognostic marker for head and neck squamous cell carcinoma
by: Yunshan Li, et al.
Published: (2024-05-01)

An effective prognostic model in colon adenocarcinoma composed of cuproptosis-related epigenetic regulators
by: Yang Liu, et al.
Published: (2023-08-01)

A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma
by: Lei Liu, et al.
Published: (2021-09-01)

m6A-related lncRNA-based immune infiltration characteristic analysis and prognostic model for colonic adenocarcinoma
by: Hao-lun Wang, et al.
Published: (2023-02-01)

Prognostic and immune infiltration significance of ARID1A in TCGA molecular subtypes of gastric adenocarcinoma
by: Zhenkun Zhang, et al.
Published: (2023-08-01)

Characterization of chromatin regulators in hepatocellular carcinoma to guide clinical therapy
by: Xiangen Jia, et al.
Published: (2022-08-01)

Comprehensive analysis of mitochondrial-related gene signature for prognosis, tumor immune microenvironment evaluation, and candidate drug development in colon cancer
by: Hao Hao Wu, et al.
Published: (2025-02-01)

Experimental verification and validation of immune biomarkers based on chromatin regulators in ischemic stroke
by: Beibei Yu, et al.
Published: (2022-08-01)

Immunological role and prognostic value of somatostatin receptor family members in colon adenocarcinoma
by: Xiaoqian Yu, et al.
Published: (2023-10-01)

The correlation of WDR76 expression with survival outcomes and immune infiltrates in lung adenocarcinoma
by: Likui Fang, et al.
Published: (2021-10-01)

Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma
by: Jie Zhu, et al.
Published: (2020-01-01)

The Prognostic Model and Drug Sensitivity of LKB1-Mutant Lung Adenocarcinoma Based on Immune Landscape
by: Guanghui Wang, et al.
Published: (2022-06-01)

Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer
by: Hua-jun Cai, et al.
Published: (2021-10-01)

PANoptosis-related genes function as efficient prognostic biomarkers in colon adenocarcinoma
by: Yang Liu, et al.
Published: (2024-03-01)

Bioinformatic analysis of FOXN3 expression and prognostic value in pancreatic cancer
by: Wei Yu, et al.
Published: (2022-10-01)

Predicting survival in bladder cancer with a novel apoptotic gene-related prognostic model
by: Ding-ming Song, et al.
Published: (2024-11-01)